The device gained approval in the US in 2019 and received CE marking for use in the EU in 2014.

Cardiac device therapy has significantly evolved since the introduction of the first implantable pacemaker and the subsequent ...

Jan 15 (Reuters) - Boston Scientific said on Thursday it will buy medtech firm Penumbra in a deal valued at about $14.5 ...

Study is Expected to Be One of the Largest Therapeutic Cardiac Device Trials in Heart Failure Ever Performed, and is ...

This morning Murj, developer of a digital data collection platform for implantable cardiac devices, announced that it raked in $8.5 million in a series B financing led by Longitude Capital, with ...

National registry study ranks strategies by initial, final success ...

Atrial fibrillation is one of the most common kinds of arrhythmia, causing the heart not to contract properly in order to ...

CINCINNATI, Ohio — Children and adolescents with pacemakers and implantable cardiac defibrillators (ICDs)--and their parents--suffer from a poorer quality of life than both healthy children and ...

Heart failure affects 6.5 million people in the U.S., with an additional 550,000 newly diagnosed each year. Heart failure hospitalizations are a leading cause of admissions for those 65 and older, ...

Implantable cardiac devices may pose a heightened risk of infections, complications and morbidity, according to a study published in the Journal of the American Medical Association. For the study, ...

Heart disease, also called cardiovascular disease, can have serious consequences. It's the leading cause of death for adults in the U.S. Medical devices approved by the U.S. Food and Drug ...